T1Type1Cure
A surgeon in scrubs celebrates after a successful surgery in an operating room.
Javid Hashimov (Pexels) / Pexels License
Cure & Advancements/June 1, 2026/2 min read

Islet Transplantation: A Potential Path Forward for Type 1 Diabetes

Researchers are exploring islet transplantation as a way to restore insulin-producing function in people with Type 1 diabetes. Understanding how this approach works—and its current limitations—can help patients and families evaluate emerging options.

cure researchbeta cellsadvancements

Key takeaways

  • Islet transplantation aims to replace insulin-producing cells that the immune system has attacked in Type 1 diabetes
  • The approach remains experimental and faces significant technical and immunological challenges
  • This is not a cure, but rather a potential therapeutic strategy to improve blood sugar management
  • Research into islet transplantation continues to evolve as scientists work to overcome barriers to long-term success

What Is Islet Transplantation?

In Type 1 diabetes, the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. Islet transplantation is an experimental approach that aims to replace these lost cells by transplanting new insulin-producing islets into a person with Type 1 diabetes.

The goal of islet transplantation is to restore the pancreas's ability to produce and regulate insulin naturally, potentially reducing or eliminating the need for daily insulin injections and improving blood sugar control.

Where Islet Transplantation Stands Today

Islet transplantation remains an area of active research rather than a widely available treatment. Scientists continue to work on fundamental challenges, including sourcing adequate numbers of healthy islets, protecting transplanted cells from the immune system, and ensuring long-term survival and function of the transplanted tissue.

While promising, current islet transplantation approaches have not yet achieved the reliability and accessibility needed for routine clinical use in Type 1 diabetes management.

The Immune System Challenge

A central obstacle to islet transplantation success is the same problem that causes Type 1 diabetes in the first place: immune system dysfunction. Even after a successful transplant, the recipient's immune system may attack the new islets, just as it attacked the original beta cells.

Researchers are investigating immunosuppressive strategies and other approaches to help protect transplanted islets from immune rejection, but this remains an active area of investigation.

The Path Forward

The evolving landscape of Type 1 diabetes treatment includes islet transplantation alongside other emerging therapies and approaches. As research continues, scientists are refining techniques to improve transplant success rates and develop more targeted ways to manage immune response.

For people with Type 1 diabetes and their families, staying informed about emerging options—while maintaining realistic expectations about what current science can deliver—helps support informed conversations with healthcare providers about individual treatment goals.

Evidence label

Origin: YouTube / MedEvidence Articles (Video report). Evidence: Video report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.

More evidence-labeled coverage across the Type1Cure library.